A detailed history of Armistice Capital, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 6,196,000 shares of TMCI stock, worth $43.1 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
6,196,000
Previous 5,360,000 15.6%
Holding current value
$43.1 Million
Previous $35.6 Million 0.82%
% of portfolio
0.6%
Previous 0.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $8.45 $4.19 Million - $7.06 Million
836,000 Added 15.6%
6,196,000 $35.9 Million
Q2 2024

Aug 14, 2024

BUY
$4.17 - $12.62 $12.3 Million - $37.4 Million
2,960,000 Added 123.33%
5,360,000 $35.6 Million
Q1 2024

May 15, 2024

SELL
$11.48 - $15.86 $5.23 Million - $7.23 Million
-456,000 Reduced 15.97%
2,400,000 $31.3 Million
Q4 2023

Feb 13, 2024

BUY
$6.03 - $12.88 $17.2 Million - $36.8 Million
2,856,000 New
2,856,000 $36.4 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $386M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.